Compare EBON & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EBON | COCH |
|---|---|---|
| Founded | 2010 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 24.4M |
| IPO Year | 2020 | N/A |
| Metric | EBON | COCH |
|---|---|---|
| Price | $2.34 | $0.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 4.0K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $0.36 |
| 52 Week High | $5.90 | $1.91 |
| Indicator | EBON | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 35.21 | 52.49 |
| Support Level | $2.30 | $0.65 |
| Resistance Level | $3.76 | $0.73 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 5.56 | 46.00 |
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.